AstraZeneca profit up on strong sales of cancer drugs
British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.
21 hours ago
0
0
British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.
21 hours ago
0
0
Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.
Mar 14, 2024
0
0
British drugs group AstraZeneca on Thursday said its net profit almost doubled to $6 billion last year, with a strong cancer division helping offset a wipeout for sales of COVID treatments.
Feb 8, 2024
0
0
Novo Nordisk A/S and Eli Lilly & Co. are touting pill versions of their blockbuster weight-loss drugs that could come as soon as next year. But if you're expecting something cheaper and with fewer side effects, think again.
Nov 20, 2023
0
1
Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence.
Sep 29, 2023
0
1
Using AI to interpret images from a handheld ultrasound device is comparable at detecting how well the heart pumps as the gold-standard of diagnosis currently used in the NHS. The breakthrough new findings suggest that the ...
Aug 28, 2023
0
3
Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimize China-related risks, the Financial Times reported on Monday.
Jun 19, 2023
0
2
A new antibody drug to help fight COVID-19 infection in immune-compromised people may be available by the end of the year.
May 1, 2023
0
33
A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.
Feb 22, 2023
1
215
Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.
Feb 9, 2023
0
2
AstraZeneca plc (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
This text uses material from Wikipedia, licensed under CC BY-SA